ProStrakan, Inc., a commercial subsidiary of Kyowa Kirin Co, Ltd, with US headquarters in Bridgewater, NJ, is a growing specialty pharmaceutical company focused on developing and commercializing prescription medicines that help improve the health and well-being of people through innovative drug developments and state-of-the-art technologies in oncology, nephrology, and immunology.